Procter & Gamble reported its fiscal fourth quarter before Wednesday’s open. Net sales were $21.2 billion, up 2% from a year ago and short of the $21.38 billion analysts surveyed by LSEG expected. Core earnings came in at $1.43 a share against $1.41 expected — a beat, and still down 3% year over year. On a GAAP basis, net income fell to $3.04 billion, or $1.26 a share, from $3.62 billion and $1.48 a year earlier. The stock dropped more than 3% before the bell.
None of that is the number that matters. This is: organic sales were unchanged. Zero. And the company’s own release breaks it down further — volume, pricing and mix each had a neutral impact on the quarter.
Read that again, because it is unusual. A flat organic line normally means something is offsetting something else: volume down, price up, or the reverse. P&G got flat the hard way. Nobody bought more. Nobody paid more. Nothing shifted toward the pricier shelf. Three separate levers, three zeros.
The company that always has pricing power didn’t use it
P&G is the reference case for pricing power in consumer goods. It sells things households buy whether or not the quarter is good, and for three years it demonstrated that it could pass costs through and keep the volume. That was the entire bull case through the inflation cycle.
This quarter it passed through nothing. Management pointed at higher commodity costs, tariffs and higher interest rates, and CEO Shailesh Jejurikar described a “challenging geopolitical and economic environment.” Beauty was the standout with 3% volume growth. The rest of the portfolio did not carry it.
The full fiscal year tells the same story in slower motion: net sales up 3%, organic sales up 1%, diluted EPS up 2%, core EPS up 1%. For fiscal 2027, P&G guided all-in and organic sales growth of 1–3% — and that organic range already absorbs a 30-to-50 basis point headwind from brands, product forms and go-to-market channels the company is discontinuing. Diluted EPS is guided to grow 1–5% off the fiscal 2026 base of $6.62.
Our take: P&G is the widest-aperture read on the consumer that exists in a single earnings release — roughly five billion people, most product categories, most countries, all in one print. When that company reports zero volume growth and zero pricing at the same time, it is not a P&G problem. It is a demand signal, and it is arriving with awkward timing. The Fed announces at 2 p.m. ET with futures still assigning a real chance to a hike today and much higher odds by September, and the case for hiking rests on an economy hot enough to keep prices rising. P&G just said it could not raise prices at all. Two data points in opposite directions, one afternoon. Watch which one Kevin Warsh cites in the press conference — and remember that the best consumer spending number in four years came with an expiration date attached to a tournament that ended July 19.
What to watch
- The 2 p.m. ET statement and the 2:30 press conference. A hold plus hawkish language is the consensus setup. Any acknowledgment of softening demand is the tell that staples prints like this one are landing at the Fed.
- Whether the rest of staples confirms. One flat quarter is a company. Three is a cycle. Watch the packaged-food and household names reporting into next week for the same volume-and-price double zero.
- Fiscal 2027 organic guidance versus the discontinuations. Guiding 1–3% while removing 30–50 basis points of your own revenue is a portfolio decision, not a demand forecast. If the low end holds, the pruning is doing the work.
- Input costs. Tariffs and commodities were both named as pressure. With crude jumping again on renewed Middle East strikes, the cost side of this P&L is not finished moving.
The board also named Jejurikar chair effective August 1, consolidating the CEO and chair roles. That is a governance change most quarters would lead with. This quarter it is the fourth-most-interesting line in the release.